StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Pharma-Bio Serv's gross profit for the twelve months ending Jul 31, 2026 was $3.07M, up 6.1% year over year. For fiscal 2025 it was $2.91M, up 15.7% from the year before. Over ten years it grew -9.0% a year on average. The highest annual figure on record is $11.83M in fiscal 2013.

Annual gross profit

PeriodPeriod endValueChange
FY2025Oct 31, 2025$2.91M+15.7%
FY2024Oct 31, 2024$2.52M-50.3%
FY2023Oct 31, 2023$5.07M+3.8%
FY2022Oct 31, 2022$4.88M-8.9%
FY2021Oct 31, 2021$5.36M-19.6%
FY2020Oct 31, 2020$6.67M+7.9%
FY2019Oct 31, 2019$6.18M+8.6%
FY2018Oct 31, 2018$5.69M+48.0%
FY2017Oct 31, 2017$3.84M-33.6%
FY2016Oct 31, 2016$5.78M-22.7%
FY2015Oct 31, 2015$7.48M-16.6%
FY2014Oct 31, 2014$8.97M-24.2%
FY2013Oct 31, 2013$11.83M+19.9%
FY2012Oct 31, 2012$9.87M+43.9%
FY2011Oct 31, 2011$6.86M+102.2%
FY2010Oct 31, 2010$3.39M–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026$691.73K+20.5%
Q2 FY2026CQ1 2026Apr 30, 2026$902.04K+10.2%
Q1 FY2026CQ4 2025Jan 31, 2026$722.37K-6.0%
Q4 FY2025CQ3 2025Oct 31, 2025$748.94K+3.1%
Q3 FY2025CQ2 2025Jul 31, 2025$574.26K-9.6%
Q2 FY2025CQ1 2025Apr 30, 2025$818.73K+32.4%
Q1 FY2025CQ4 2024Jan 31, 2025$768.11K+43.4%
Q4 FY2024CQ3 2024Oct 31, 2024$726.57K-21.9%
Q3 FY2024CQ2 2024Jul 31, 2024$635.38K-59.0%
Q2 FY2024CQ1 2024Apr 30, 2024$618.48K-54.1%
Q1 FY2024CQ4 2023Jan 31, 2024$535.61K-56.8%
Q4 FY2023CQ3 2023Oct 31, 2023$929.81K-75.4%
Q3 FY2023CQ2 2023Jul 31, 2023$1.55M–
Q2 FY2023CQ1 2023Apr 30, 2023$1.35M-10.2%
Q1 FY2023CQ4 2022Jan 31, 2023$1.24M-1.2%
Q1 FY2022CQ4 2021Jul 31, 2022$3.77M+192.3%
Q2 FY2022CQ1 2022Apr 30, 2022-$1.31M-199.8%
Q4 FY2021CQ3 2021Oct 31, 2021$1.50M+10.4%
Q3 FY2021CQ2 2021Jul 31, 2021$1.26M-32.3%
Q2 FY2021CQ1 2021Apr 30, 2021$1.29M-30.9%
Q1 FY2021CQ4 2020Jan 31, 2021$1.32M-17.1%
Q4 FY2020CQ3 2020Oct 31, 2020$1.36M-11.7%
Q3 FY2020CQ2 2020Jul 31, 2020$1.85M+18.4%
Q2 FY2020CQ1 2020Apr 30, 2020$1.87M+17.3%
Q1 FY2020CQ4 2019Jan 31, 2020$1.59M+7.2%
Q4 FY2019CQ3 2019Oct 31, 2019$1.54M-17.9%
Q3 FY2019CQ2 2019Jul 31, 2019$1.57M-1.8%
Q2 FY2019CQ1 2019Apr 30, 2019$1.59M+53.7%
Q1 FY2019CQ4 2018Jan 31, 2019$1.48M+25.2%
Q4 FY2018CQ3 2018Oct 31, 2018$1.87M+123.0%
Q3 FY2018CQ2 2018Jul 31, 2018$1.59M+71.7%
Q2 FY2018CQ1 2018Apr 30, 2018$1.04M-0.4%
Q1 FY2018CQ4 2017Jan 31, 2018$1.18M+14.5%
Q4 FY2017CQ3 2017Oct 31, 2017$840.68K-21.8%
Q3 FY2017CQ2 2017Jul 31, 2017$928.11K-34.9%
Q2 FY2017CQ1 2017Apr 30, 2017$1.04M–
Q1 FY2017CQ4 2016Jan 31, 2017$1.03M–
Q4 FY2016CQ3 2016Oct 31, 2016$1.07M–
Q3 FY2016CQ2 2016Jul 31, 2016$1.43M–

More Pharma-Bio Serv figures

See a number that looks wrong?